Scott Jakes
About Scott Jakes
Scott Jakes is a Scientific Review Officer at the National Institutes of Health, where he oversees the peer review process for small business applications focused on vaccine development. He has a decade of experience as a Director at Boehringer Ingelheim and specializes in kinase-based drug discovery and protein phosphorylation.
Work at National Institutes of Health
Scott Jakes has served as a Scientific Review Officer at the National Institutes of Health (NIH) since 2010. In this role, he oversees the peer review process for small business applications that focus on vaccine development. His responsibilities include evaluating the scientific merit of proposals and ensuring that the review process adheres to NIH standards. Jakes has contributed to the NIH's mission by facilitating funding for innovative research in the biomedical field.
Previous Experience at Boehringer Ingelheim
Prior to his tenure at the NIH, Scott Jakes worked at Boehringer Ingelheim from 1998 to 2008, where he held the position of Director for a decade. During his time at Boehringer Ingelheim, he gained valuable experience in the pharmaceutical industry, focusing on drug development processes and project management. His work contributed to the advancement of various therapeutic areas.
Education and Expertise
Scott Jakes studied at the Medical University of Ohio at Toledo, where he developed a strong foundation in biomedical sciences. He possesses extensive knowledge in signal transduction and enzymology, which are critical areas in drug discovery and development. His expertise extends to kinase-based drug discovery and protein phosphorylation, making him well-versed in the mechanisms of action for various therapeutic agents.
Background in Drug Discovery
Scott Jakes has a background in the pre-LO phases of new chemical entity (NCE) drug discovery. His experience includes target identification and assay development, which are essential steps in the drug development pipeline. Jakes's understanding of these processes supports his role in the peer review of applications related to primary immunodeficiency diseases, where he evaluates innovative approaches to treatment.
Specialization in Peer Review
Scott Jakes specializes in the peer review of applications related to primary immunodeficiency diseases. His role involves assessing the scientific validity of research proposals and ensuring that they meet the rigorous standards set by the NIH. Through his work, he plays a critical role in advancing research that addresses significant health challenges.